サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1217429

抗うつ薬の世界市場レポート 2023年

Antidepressants Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.88円
抗うつ薬の世界市場レポート 2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

抗うつ薬の世界市場は、2021年の156億1000万米ドルから2022年には164億4000万米ドルへ、年平均成長率（CAGR）5.4％で成長すると予想されています。ロシア・ウクライナ戦争は、少なくとも短期的には、COVID-19の大流行からの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。抗うつ薬市場は、2026年にはCAGR8.2%で225億7000万米ドルに達すると予想されます。

2022年の抗うつ薬市場では、北米が最大の地域となりました。中東は予測期間中に最も大きく成長する地域であると予想されます。抗うつ薬市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

世界的に、精神疾患の症例が増加していることが、抗うつ薬産業の成長の主な要因です。多くの顧客が、うつ病、不安障害、その他の精神疾患の対策として、これらの薬に依存しているからです。抗うつ薬は、うつ病、強迫性障害、小児尿崩症、大うつ病性障害、重度の不安障害、双極性障害、心的外傷後ストレス障害（PTSD）、社会不安障害などの症状で使用されています。世界的に見ると、うつ病患者の割合は2％から6％と幅があり、高齢者は他の年齢層と比較してうつ病のリスクが高いと言われています。WHOによると、2020年には全世界で約2億6,400万人がうつ病に罹患していると言われています。したがって、精神疾患の症例の増加は、抗うつ薬市場の成長を促進することが期待されます。

目次

第1章 エグゼクティブサマリー

第2章 抗うつ薬市場の特徴

第3章 抗うつ薬市場の動向と戦略

第4章 抗うつ薬市場- マクロ経済シナリオ

第5章 抗うつ薬の市場規模と成長

  • 世界の抗うつ薬市場の実績、2017年から2022年
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の抗うつ薬市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 抗うつ薬市場セグメンテーション

  • 世界の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 選択的セロトニン再取り込み阻害剤（SSRI）
  • セロトニン-ノルエピネフリン再取り込み阻害剤（SNRI）
  • 三環系抗うつ薬（TCA）
  • モノアミン酸化酵素阻害剤（MAOI）
  • 世界の抗うつ薬市場、薬物クラス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • モノアミンオキシダーゼ阻害剤
  • セロトニン拮抗薬および再取り込み阻害薬
  • セロトニン-ノルエピネフリン再取り込み阻害薬
  • 選択的セロトニン再取り込み阻害薬
  • 三環系抗うつ薬3
  • 世界の抗うつ薬市場、抑うつ障害別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 大鬱病性障害
  • 強迫性障害
  • 全般性不安障害
  • パニック障害

第7章 抗うつ薬市場の地域および国の分析

  • 世界の抗うつ薬市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界の抗うつ薬市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋の抗うつ薬市場

  • アジア太平洋の抗うつ薬市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国の抗うつ薬市場

  • 中国の抗うつ薬市場概要
  • 中国の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドの抗うつ薬市場

  • インドの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本の抗うつ薬市場

  • 日本の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアの抗うつ薬市場

  • オーストラリアの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアの抗うつ薬市場

  • インドネシアの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国の抗うつ薬市場

  • 韓国の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧の抗うつ薬市場

  • 西欧の抗うつ薬市場概要
  • 西欧の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国の抗うつ薬市場

  • 英国の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツの抗うつ薬市場

  • ドイツの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスの抗うつ薬市場

  • フランスの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧の抗うつ薬市場

  • 東欧の抗うつ薬市場概要
  • 東欧の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアの抗うつ薬市場

  • ロシアの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米の抗うつ薬市場

  • 北米の抗うつ薬市場概要
  • 北米の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国の抗うつ薬市場

  • 米国の抗うつ薬市場概要
  • 米国の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米の抗うつ薬市場

  • 南米の抗うつ薬市場概要
  • 南米の抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルの抗うつ薬市場

  • ブラジルの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東の抗うつ薬市場

  • 中東の抗うつ薬市場概要
  • 中東抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカの抗うつ薬市場

  • アフリカの抗うつ薬市場概要
  • アフリカの抗うつ薬市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 抗うつ薬市場の競合情勢と企業プロファイル

  • 抗うつ薬市場の競合情勢
  • 抗うつ薬市場の企業プロファイル
    • Allergan PLC
    • AstraZeneca
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • H. Lundbeck AS

第28章 抗うつ薬パイプライン分析

第29章 抗うつ薬市場における主要な合併と買収

第30章 抗うつ薬市場の将来の見通しと潜在的な分析

第31章 付録

目次
Product Code: r2537

“Antidepressants Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antidepressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antidepressants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antidepressants market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI); Serotonin-norepinephrine Reuptake Inhibitor (SNRI); Tricyclic Antidepressant (TCA); Monoamine Oxidase Inhibitor (MAOI)

2) By Drug Class: Monoamine Oxidase Inhibitors; Serotonin Antagonist And Reuptake Inhibitors; Serotonin-Norepinephrine Reuptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Tricyclic Antidepressants

3) By Depressive Disorder: Major Depressive Disorder; Obsessive-Compulsive Disorder; Generalized Anxiety Disorder; Panic Disorder

Companies Mentioned: Allergan PLC; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline PLC; H. Lundbeck AS

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the antidepressants market are: Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd, Alkermes, Bristol Myers Squibb Company, Teva Pharmaceutical Industries, Eli Lilly and Co., Takeda Pharmaceutical Co. Ltd, Forest laboratories and Akeda Pharmaceutical.

The global antidepressants market is expected to grow from $15.61 billion in 2021 to $16.44 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The antidepressants market is expected to reach $22.57 billion in 2026 at a CAGR of 8.2%.

The antidepressants market consists of sales of duloxetine, desvenlafaxine, vilazodone, citalopram, and sertraline. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent.

North America was the largest region in the antidepressants market in 2022. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main product types of antidepressants are selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant (TCA), and monoamine oxidase inhibitor (MAOI). SSRIs (selective serotonin reuptake inhibitors) are a type of medication that is commonly used to treat depression and a few other mental illnesses. The various drug class includes monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants that are used for the treatment of the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder.

The antidepressants market has also surged during the COVID-19 outbreak. The increasing number of cases and fatalities is affecting mental health by elevating anxiety worldwide. People who are already living with mental health problems are experiencing increased stress levels over the COVID-19 outbreak. This has triggered the demand for antidepressant drugs.

Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder, and other mental diseases. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder. Globally, the percentage of people with depression varies from 2% to 6%, and the elderly are at greater risk of depression compared to other age groups. According to WHO, in 2020, about 264 million people of all ages worldwide suffered from depression. Therefore, rising cases of mental health disorders are expected to drive the growth of the antidepressant market.

The side effects of antidepressant drugs are a key factor hampering the growth of the antidepressant market. For instance, the antidepressants Lexapro (escitalopram) and Celexa (citalopram), both are used to treat depression and Lexapro also helps for treating anxiety. Lexapro and Celexa can cause side effects common to others which include nausea, sleeplessness, sweating, dry mouth, and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures, and vision issues. Therefore, the side effects of antidepressant drugs are expected to limit the growth of the antidepressant market.

The treatment of resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviors. For instance, Food and Drug Administration (FDA) approved a new ketamine depression drug esketamine which is one-half of the ketamine compound. The drug must be administered as a nasal spray and patients must be taking another antidepressant at the same time. Also, the drugs can be prescribed to only those patients who have (unsuccessfully) tried two antidepressants before.

In October 2021, Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, and other biotech products, announced that it has entered into a framework agreement to acquire a majority stake in Beijing Wonner Biotech Co., Ltd., for a deal amount of $30 million. Through this acquisition, Shineco aims to jointly develop SNG, a rapid-acting antidepressant natural innovative medicine. Beijing Winner is a biotechnology company based in China that specializes in the research and development of natural medicines and related products.

The countries covered in the antidepressants market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The antidepressants market research report is one of a series of new reports from The Business Research Company that provides antidepressants market statistics, including antidepressants industry global market size, regional shares, competitors with an antidepressants market share, detailed antidepressants market segments, market trends, and opportunities, and any further data you may need to thrive in the antidepressants industry. This antidepressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Antidepressants Market Characteristics

3. Antidepressants Market Trends And Strategies

4. Antidepressants Market - Macro Economic Scenario

4.1 COVID-19 Impact On Antidepressants Market

4.2 Ukraine-Russia War Impact On Antidepressants Market

4.3 Impact Of High Inflation On Antidepressants Market

5. Antidepressants Market Size And Growth

  • 5.1. Global Antidepressants Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antidepressants Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antidepressants Market Segmentation

  • 6.1. Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Selective Serotonin Reuptake Inhibitor (SSRI)
  • Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
  • Tricyclic Antidepressant (TCA)
  • Monoamine Oxidase Inhibitor (MAOI)
  • 6.2. Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Monoamine oxidase inhibitors
  • Serotonin antagonist and reuptake inhibitors
  • Serotonin-norepinephrine reuptake inhibitors
  • Selective serotonin reuptake inhibitors
  • Tricyclic antidepressants 3
  • 6.3. Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Major Depressive Disorder
  • Obsessive-Compulsive Disorder
  • Generalized Anxiety Disorder
  • Panic Disorder

7. Antidepressants Market Regional And Country Analysis

  • 7.1. Global Antidepressants Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Antidepressants Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Antidepressants Market

  • 8.1. Asia-Pacific Antidepressants Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Antidepressants Market

  • 9.1. China Antidepressants Market Overview
  • 9.2. China Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Antidepressants Market

  • 10.1. India Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Antidepressants Market

  • 11.1. Japan Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Antidepressants Market

  • 12.1. Australia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Antidepressants Market

  • 13.1. Indonesia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Antidepressants Market

  • 14.1. South Korea Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Antidepressants Market

  • 15.1. Western Europe Antidepressants Market Overview
  • 15.2. Western Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Antidepressants Market

  • 16.1. UK Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Antidepressants Market

  • 17.1. Germany Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Antidepressants Market

  • 18.1. France Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Antidepressants Market

  • 19.1. Eastern Europe Antidepressants Market Overview
  • 19.2. Eastern Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Antidepressants Market

  • 20.1. Russia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Antidepressants Market

  • 21.1. North America Antidepressants Market Overview
  • 21.2. North America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Antidepressants Market

  • 22.1. USA Antidepressants Market Overview
  • 22.2. USA Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Antidepressants Market

  • 23.1. South America Antidepressants Market Overview
  • 23.2. South America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Antidepressants Market

  • 24.1. Brazil Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Antidepressants Market

  • 25.1. Middle East Antidepressants Market Overview
  • 25.2. Middle East Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Antidepressants Market

  • 26.1. Africa Antidepressants Market Overview
  • 26.2. Africa Antidepressants Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Antidepressants Market Competitive Landscape And Company Profiles

  • 27.1. Antidepressants Market Competitive Landscape
  • 27.2. Antidepressants Market Company Profiles
    • 27.2.1. Allergan PLC
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AstraZeneca
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Eli Lilly and Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. GlaxoSmithKline PLC
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. H. Lundbeck AS
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antidepressants Pipeline Analysis

29. Key Mergers And Acquisitions In The Antidepressants Market

30. Antidepressants Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Historic And Forecast Inflation Rates
  • 31.4. Research Inquiries
  • 31.5. The Business Research Company
  • 31.6. Copyright And Disclaimer